(Reuters) - A small early-stage trial of Ariad Pharmaceuticals Inc's experimental pill AP26113 showed it shrank tumors in eight out of 11 lung cancer patients with a genetic mutation in a gene known as ALK. The drug, called '113 for short,...
Source: http://health.yahoo.net/news/s/nm/ariad-lung-cancer-drug-shrinks-tumors-in-small-trial
Rachel Zoe Christina Katherine Jackson Chad Ochocinco
No comments:
Post a Comment
Note: only a member of this blog may post a comment.